Endothelial dysfunction in experimental models of arterial hypertension: Cause or consequence?

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Bernatova, Iveta ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; ENDOTHELIN 1; ENDOTHELIUM DERIVED CONSTRICTING FACTOR; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; GUANYLATE CYCLASE; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

DIET; DIET INDUCED HYPERTENSION; DISEASE CLASSIFICATION; ENDOTHELIAL DYSFUNCTION; ESSENTIAL HYPERTENSION; EXPERIMENTAL HYPERTENSION; EXPERIMENTAL MODEL; HEREDITARY HYPERTENSION; HYPERPOLARIZATION; HYPERTENSION; MODULATION; NONHUMAN; OXIDATIVE STRESS; PLEIOTROPY; REVIEW; SIGNAL TRANSDUCTION; STIMULUS; STRESS; STRESS INDUCED HYPERTENSION; VASODILATATION; ANIMAL; ARTERIAL PRESSURE; CARDIOVASCULAR DISEASES; DISEASE MODEL; ENDOTHELIUM; HUMAN; LIFE EVENT; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; ARTERIAL PRESSURE; CARDIOVASCULAR DISEASES; DISEASE MODELS, ANIMAL; ENDOTHELIUM; HUMANS; HYPERTENSION; LIFE CHANGE EVENTS; NITRIC OXIDE;

EID: 84897560514     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/598271     Document Type: Review

References (157)

1. Baker M., Rahman T., Hall D., Avery P. J., Mayosi B. M., Connell J. M. C., Farrall M., Watkins H., Keavney B., The C-532T polymorphism of the angiotensinogen gene is associated with pulse pressure: a possible explanation for heterogeneity in genetic association studies of AGT and hypertension. International Journal of Epidemiology 2007 36 6 1356 1362 2-s2.0-36949020051 10.1093/ije/dym213 (Pubitemid 350239005)
2. Niu W., Qi Y., Hou S., Zhou W., Qiu C., Correlation of angiotensin-converting enzyme 2 gene polymorphisms with stage 2 hypertension in Han Chinese. Translational Research 2007 150 6 374 380 2-s2.0-36049047073 10.1016/j.trsl.2007.06.002 (Pubitemid 350101437)
3. Manunta P., Citterio L., Lanzani C., Ferrandi M., Adducin polymorphisms and the treatment of hypertension. Pharmacogenomics 2007 8 5 465 472 2-s2.0-34248569586 10.2217/14622416.8.5.465 (Pubitemid 46746353)
4. Mo W., Zhang G., Yang T., Dai X., Li H., Zeng H., Liu J., Tan Y., Zhou H., Liu Z., The genetic polymorphisms of β 3-adrenergic receptor (AR) Trp64Arg and β 2-AR Gln27Glu are associated with obesity in Chinese male hypertensive patients. Clinical Chemistry and Laboratory Medicine 2007 45 4 493 498 2-s2.0-34247350423 10.1515/CCLM.2007.089 (Pubitemid 46632210)
5. Nejatizadeh A., Kumar R., Stobdan T., Goyal A. K., Sikdar S., Gupta M., Javed S., Pasha M. A. Q., Endothelial nitric oxide synthase gene haplotypes and circulating nitric oxide levels significantly associate with risk of essential hypertension. Free Radical Biology and Medicine 2008 44 11 1912 1918 2-s2.0-43049162811 10.1016/j.freeradbiomed.2008.02.004
6. Levy D., DeStefano A. L., Larson M. G., O'Donnell C. J., Lifton R. P., Gavras H., Cupples L. A., Myers R. H., Evidence for a gene influencing blood pressure on chromosome 17: genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the Framingham Heart study. Hypertension 2000 36 4 477 483 2-s2.0-0033770421
7. Jurkovicova D., Sedlakova B., Riecansky I., Goncalvesova E., Penesova A., Kvetnansky R., Krizanova O., Cardiovascular diseases and molecular variants of the renin-angiotensin system components in Slovak population. General Physiology and Biophysics 2007 26 1 27 32 2-s2.0-34250796762 (Pubitemid 46979310)
8. He Q., Fan C., Yu M., Wallar G., Zhang Z. F., Wang L., Zhang X., Hu R., Associations of ACE gene insertion/deletion polymorphism, ACE activity, and ACE mRNA expression with hypertension in a Chinese population. PLoS ONE 2013 8 e75870
9. Ma Y., Ni W., Zhu W., Xiong Y., Deng X., Association of genetic polymorphisms of CYP 2C19 with hypertension in a Chinese Han population. Blood Pressure 2011 20 3 166 170 2-s2.0-79957519285 10.3109/08037051.2010.542640
10. Petrovic D., Association of the -262C/T polymorphism in the catalase gene promoter and the C242T polymorphism of the NADPH oxidase P22phox gene with essential arterial hypertension in patients with diabetes mellitus type 2. Clinical and Experimental Hypertension 2014 36 1 36 39
11. Zhang L. N., Ji L. D., Fei L. J., Yuan F., Zhang Y. M., Xu J., Association between polymorphisms of alpha-adducin gene and essential hypertension in Chinese population. BioMed Research International 2013 2013 5 451094 10.1155/2013/451094
12. Török J., Participation of nitric oxide in different models of experimental hypertension. Physiological Research 2008 57 6 813 825 2-s2.0-61549096588
13. Bunting S., Gryglewski R., Moncada S., Vane J. R., Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregation. Prostaglandins 1976 12 6 897 913 2-s2.0-0017041860 (Pubitemid 8015243)
14. Weksler B. B., Marcus A. J., Jaffe E. A., Synthesis of prostaglandin I2 (prostacyclin) by cultured human and bovine endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 1977 74 9 3922 3926 2-s2.0-0017527971 (Pubitemid 8193536)
15. Furchgott R. F., Zawadzki J. V., The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980 288 5789 373 376 2-s2.0-0019195506 (Pubitemid 11169009)
16. Zhang Q., Church J. E., Jagnandan D., Catravas J. D., Sessa W. C., Fulton D., Functional relevance of Golgi- and plasma membrane-localized endothelial NO synthase in reconstituted endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2006 26 5 1015 1021 2-s2.0-33646451361 10.1161/01.ATV. 0000216044.49494.c4 (Pubitemid 43732106)
17. Rafikov R., Fonseca F. V., Kumar S., Pardo D., Darragh C., Elms S., Fulton D., Black S. M., eNOS activation and NO function: structural motifs responsible for the posttranslational control of endothelial nitric oxide synthase activity. Journal of Endocrinology 2011 210 3 271 284 2-s2.0-80052758036 10.1530/JOE-11-0083
18. Kopincova J., Puzserova A., Bernatova I., L-NAME in the cardiovascular system-nitric oxide synthase activator? Pharmacological Reports 2012 64 511 520
19. Förstermann U., Sessa W. C., Nitric oxide synthases: regulation and function. European Heart Journal 2012 33 7 829d 837d 2-s2.0-84859487532
20. Kopincová J., Púzserová A., Bernátová I., Chronic low-dose L-NAME treatment effect on cardiovascular system of borderline hypertensive rats: feedback regulation? Neuroendocrinology Letters 2008 29 5 784 789 2-s2.0-57149142784
21. Bernátová I., Pecháňová O., Kristek F., Mechanism of structural remodelling of the rat aorta during long-term N(G)-nitro-L-arginine methyl ester treatment. Japanese Journal of Pharmacology 1999 81 1 99 106 2-s2.0-0032832357 10.1254/jjp.81.99 (Pubitemid 29479061)
22. Garg U. C., Hassid A., Mechanisms of nitrosothio-induced antimitogenesis in aortic smooth muscle cells. European Journal of Pharmacology 1993 237 2-3 243 249 2-s2.0-0027336672 (Pubitemid 23201833)
23. Shimokawa H., Yasutake H., Fujii K., Owada M. K., Nakaike R., Fukumoto Y., Takayanagi T., Nagao T., Egashira K., Fujishima M., Takeshita A., The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. Journal of Cardiovascular Pharmacology 1996 28 5 703 711 2-s2.0-10544239533 10.1097/00005344-199611000-00014 (Pubitemid 26397030)
24. Parkington H. C., Coleman H. A., Tare M., Prostacyclin and endothelium-dependent hyperpolarization. Pharmacological Research 2004 49 6 509 514 2-s2.0-1542407655 10.1016/j.phrs.2003.11.012 (Pubitemid 38338660)
25. Davidge S. T., Baker P. N., McLaughlin M. K., Roberts J. M., Nitric oxide produced by endothelial cells increases production of eicosanoids through activation of prostaglandin H synthase. Circulation Research 1995 77 2 274 283 2-s2.0-0029146579
26. Niwano K., Arai M., Tomaru K., Uchiyama T., Ohyama Y., Kurabayashi M., Transcriptional stimulation of the eNOS gene by the stable prostacyclin analogue beraprost is mediated through cAMP-responsive element in vascular endothelial cells: close link between PGI2 signal and NO pathways. Circulation Research 2003 93 6 523 530 2-s2.0-0141831989 10.1161/01.RES.0000091336.55487.F7 (Pubitemid 37163232)
27. 2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine γ -lyase. Science 2008 322 5901 587 590 2-s2.0-54949084607 10.1126/science.1162667
28. 2S in cardiovascular physiology. Current Pharmaceutical Biotechnology 2011 12 9 1385 1393 2-s2.0-80052221610
29. Félétou M., Vanhoutte P. M., Endothelium-dependent hyperpolarizations: past beliefs and present facts. Annals of Medicine 2007 39 7 495 516 2-s2.0-35748931462 10.1080/07853890701491000 (Pubitemid 350041557)
30. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 1998 396 6708 269 272 2-s2.0-0032548099 10.1038/24388 (Pubitemid 28541391)
31. Han J., Chen Z. W., He G. W., Acetylcholine- and sodium hydrosulfide-induced endothelium-dependent relaxation and hyperpolarization in cerebral vessels of global cerebral ischemia-reperfusion rat. Journal of Pharmacological Sciences 2013 121 318 326
32. 2S is an endothelium-derived hyperpolarizing factor. Antioxidants and Redox Signaling 2013 19 1634 1646
33. Fleming I., Busse R., Endothelium-derived epoxyeicosatrienoic acids and vascular function. Hypertension 2006 47 4 629 633 2-s2.0-33645815886 10.1161/01.HYP.0000208597.87957.89 (Pubitemid 43740225)
34. Takaki A., Morikawa K., Tsutsui M., Murayama Y., Tekes E., Yamagishi H., Ohashi J., Yada T., Yanagihara N., Shimokawa H., Crucial role of nitric oxide synthases system in endothelium-dependent hyperpolarization in mice. Journal of Experimental Medicine 2008 205 9 2053 2063 2-s2.0-51049110692 10.1084/jem.20080106
35. Bachschmid M. M., Schildknecht S., Matsui R., Zee R., Haeussler D., Cohen R. A., Pimental D., Loo B., Vascular aging: chronic oxidative stress and impairment of redox signaling-consequences for vascular homeostasis and disease. Annals of Medicine 2013 45 17 36
36. Slezak P., Puzserova A., Balis P., Sestakova N., Majzunova M., Dovinova I., Kluknavsky M., Bernatova I., Genotype-related effect of crowding stress on blood pressure and vascular function in young female rats. BioMed Research International 2014 2014 11 413629 10.1155/2014/413629
37. van der Loo B., Labugger R., Skepper J. N., Bachschmid M., Kilo J., Powell J. M., Palacios-Callender M., Erusalimsky J. D., Quaschning T., Malinski T., Gygi D., Ullrich V., Lüscher T. F., Enhanced peroxynitrite formation is associated with vascular aging. Journal of Experimental Medicine 2000 192 12 1731 1744 2-s2.0-0034684652 10.1084/jem.192.12.1731 (Pubitemid 32049766)
38. 2 in renal vasoconstriction induced by angiotensin II in diabetes and hypertension. Kidney International, Supplement 2002 62 supplement 82 S2 S7 2-s2.0-0036433038 (Pubitemid 35356988)
39. Konczalla J., Wanderer S., Mrosek J., Schuss P., Platz J., Guresir E., Seifert V., Vatter H., Crosstalk between the angiotensin and endothelin-system in the cerebrovasculature. Current Neurovascular Research 2013 10 335 345
40. D'Amours M., Lebel M., Grose J. H., Larivière R., Renal and vascular effects of chronic nitric oxide synthase inhibition: involvement of endothelin 1 and angiotensin II. Canadian Journal of Physiology and Pharmacology 1999 77 1 8 16 2-s2.0-0032989271 10.1139/cjpp-77-1-8 (Pubitemid 29297351)
41. Luscher T. F., Boulanger C. M., Dohi Y., Yang Z., Endothelium-derived contracting factors. Hypertension 1992 19 2 117 130 2-s2.0-0026532764
42. Félétou M., Cohen R. A., Vanhoutte P. M., Verbeuren T. J., TP receptors and oxidative stress. Hand in hand from endothelial dysfunction to atherosclerosis. Advances in Pharmacology 2010 60 90 106 2-s2.0-78349291477 10.1016/B978-0-12-385061-4.00004-0
43. Li J., Bian K. A., Bukoski R. D., A non-cyclo-oxygenase, non-nitric oxide relaxing factor is present in resistance arteries of normotensive but not spontaneously hypertensive rats. American Journal of the Medical Sciences 1994 307 1 7 14 2-s2.0-0028069780
44. Vanhoutte P. M., Feletou M., Taddei S., Endothelium-dependent contractions in hypertension. British Journal of Pharmacology 2005 144 4 449 458 2-s2.0-14844320534 10.1038/sj.bjp.0706042 (Pubitemid 40349452)
45. Virdis A., Colucci R., Versari D., Ghisu N., Fornai M., Antonioli L., Duranti E., Daghini E., Giannarelli C., Blandizzi C., Taddei S., Tacca M. D., Atorvastatin prevents endothelial dysfunction in mesenteric arteries from spontaneously hypertensive rats role of cyclooxygenase 2-derived contracting prostanoids. Hypertension 2009 53 6 1008 1016 2-s2.0-67049099141 10.1161/HYPERTENSIONAHA.109.132258
46. Félétou M., Verbeuren T. J., Vanhoutte P. M., Endothelium-dependent contractions in SHR: a tale of prostanoid TP and IP receptors. British Journal of Pharmacology 2009 156 4 563 574 2-s2.0-65349116560 10.1111/j.1476-5381.2008.00060.x
47. Gluais P., Lonchampt M., Morrow J. D., Vanhoutte P. M., Feletou M., Acetylcholine-induced endothelium-dependent contractions in the SHR aorta: the Janus face of prostacyclin. British Journal of Pharmacology 2005 146 6 834 845 2-s2.0-27744564624 10.1038/sj.bjp.0706390 (Pubitemid 41622250)
48. Majzunova M., Dovinova I., Barancik M., Chan J. Y., Redox signaling in pathophysiology of hypertension. Journal of Biomedical Science 2013 20, article 69
49. Sun Y., Oberley L. W., Redox regulation of transcriptional activators. Free Radical Biology and Medicine 1996 21 3 335 348 2-s2.0-0029760957 10.1016/0891-5849(96)00109-8 (Pubitemid 26271723)
50. Karin M., Takahashi T., Kapahi P., Delhase M., Chen Y., Makris C., Rothwarf D., Baud V., Natoli G., Guido F., Li N., Oxidative stress and gene expression: the AP-1 and NF- B connections. BioFactors 2001 15 2-4 87 89 2-s2.0-18344378407 (Pubitemid 34455067)
51. Touyz R. M., Schiffrin E. L., Reactive oxygen species in vascular biology: implications in hypertension. Histochemistry and Cell Biology 2004 122 4 339 352 2-s2.0-8644277006 10.1007/s00418-004-0696-7 (Pubitemid 39506592)
52. Alfadda A. A., Sallam R. M., Reactive oxygen species in health and disease. Journal of Biomedicine and Biotechnology 2012 2012 14 936486 10.1155/2012/936486
53. Puri N., Zhang F., Monu S. R., Sodhi K., Bellner L., Lamon B. D., Zhang Y., Abraham N. G., Nasjletti A., Antioxidants condition pleiotropic vascular responses to exogenous H(2)O(2): role of modulation of vascular TP receptors and the heme oxygenase system. Antioxidants and Redox Signaling 2013 18 471 480
54. Liskova S., Petrova M., Karen P., Kunes J., Zicha J., Effects of aging and hypertension on the participation of endothelium-derived constricting factor (EDCF) in norepinephrine-induced contraction of rat femoral artery. European Journal of Pharmacology 2011 667 1-3 265 270 2-s2.0-80052033789 10.1016/j.ejphar.2011.05.031
55. Evora P. R. B., An open discussion about endothelial dysfunction: is it timely to propose a classification? International Journal of Cardiology 2000 73 3 289 292 2-s2.0-0034738111 10.1016/S0167-5273(00)00223-0 (Pubitemid 30332334)
56. Rajendran P., Rengarajan T., Thangavel J., Nishigaki Y., Sakthisekaran D., Sethi G., Nishigaki I., The vascular endothelium and human diseases. International Journal of Biological Sciences 2013 9 1057 1069
57. Rees D. D., Palmer R. M. J., Moncada S., Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proceedings of the National Academy of Sciences of the United States of America 1989 86 9 3375 3378 2-s2.0-0001599370 (Pubitemid 19129614)
58. Aisaka K., Gross S. S., Griffith O. W., Levi R., N(G)-methylarginine, an inhibitor of endothelium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo? Biochemical and Biophysical Research Communications 1989 160 2 881 886 2-s2.0-0024475102 (Pubitemid 19140604)
59. Chu A., Chambers D. E., Lin C.-C., Kuehl W. D., Palmer R. M. J., Moncada S., Cobb F. R., Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs. The Journal of Clinical Investigation 1991 87 6 1964 1968 2-s2.0-0026006136
60. Weldon S. M., Winquist R. J., Madwed J. B., Differential effects of L-NAME on blood pressure and heart rate responses to acetylcholine and bradykinin in cynomolgus primates. Journal of Pharmacology and Experimental Therapeutics 1995 272 1 126 133 2-s2.0-0028816867
61. Hecker M., Mitchell J. A., Harris H. J., Katsura M., Thiemermann C., Vane J. R., Endothelial cells metabolize N(G)-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine. Biochemical and Biophysical Research Communications 1990 167 3 1037 1043 2-s2.0-0025308496 10.1016/0006-291X(90) 90627-Y (Pubitemid 20113285)
62. Vargas H. M., Ignarro L. J., Chaudhuri G., Physiological release of nitric oxide is dependent on the level of vascular tone. European Journal of Pharmacology 1990 190 3 393 397 2-s2.0-0025104627 (Pubitemid 20368241)
63. Ribeiro M. O., Antunes E., de Nucci G., Lovisolo S. M., Zatz R., Chronic inhibition of nitric oxide synthesis: a new model of arterial hypertension. Hypertension 1992 20 3 298 303 2-s2.0-0026782496
64. Delacrétaz E., Hayoz D., Osterheld M. C., Genton C. Y., Brunner H. R., Waeber B., Long-term nitric oxide synthase inhibition and distensibility of carotid artery in intact rats. Hypertension 1994 23 6 967 970 2-s2.0-0028356867 (Pubitemid 24180847)
65. Kristek F., Gerová M., Devát L., Varga I., Remodelling of septal branch of coronary artery and carotid artery in L-NAME treated rats. Physiological Research 1996 45 4 329 333 2-s2.0-0029811344 (Pubitemid 26315569)
66. Bernátová I., Pecháňová O., Šimko F., Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats. Physiological Research 1996 45 4 311 316 2-s2.0-0029816353 (Pubitemid 26315566)
67. Arnal J.-F., Warin L., Michel J.-B., Determinants of aortic cyclic guanosine monophosphate in hypertension induced by chronic inhibition of nitric oxide synthase. The Journal of Clinical Investigation 1992 90 2 647 652 2-s2.0-0026782440
68. Dananberg J., Sider R. S., Grekin R. J., Sustained hypertension induced by orally administered nitro-L-arginine. Hypertension 1993 21 3 359 363 2-s2.0-0027402809 (Pubitemid 23065176)
69. Manning R. D. Jr., Hu L., Mizelle H. L., Montani J.-P., Norton M. W., Cardiovascular responses to long-term blockade of nitric oxide synthesis. Hypertension 1993 22 1 40 48 2-s2.0-0027195225 (Pubitemid 23187381)
70. Török J., Gerová M., Vascular responses after long-term inhibition of nitric oxide synthesis in newborn dogs. Physiological Research 1996 45 4 323 328 2-s2.0-0029835130 (Pubitemid 26315568)
71. Holécyová A., Török J., Bernátová I., Pecháňová O., Restriction of nitric oxide rather than elevated blood pressure is responsible for alterations of vascular responses in nitric oxide-deficient hypertension. Physiological Research 1996 45 4 317 321 2-s2.0-0029832026 (Pubitemid 26315567)
72. Bernátová I., Pechánová O., Babál P., Kyselá S., Stvrtina S., Andriantsitohaina R., Wine polyphenols improve cardiovascular remodeling and vascular function in NO-deficient hypertension. American Journal of Physiology-Heart and Circulatory Physiology 2002 282 3 H942 H948 2-s2.0-0036081822 (Pubitemid 34654931)
73. Qu C., Leung S. W. S., Vanhoutte P. M., Man R. Y. K., Chronic inhibition of nitric-oxide synthase potentiates endothelium-dependent contractions in the rat aorta by augmenting the expression of cyclooxygenase-2. Journal of Pharmacology and Experimental Therapeutics 2010 334 2 373 380 2-s2.0-77954921263 10.1124/jpet.110.167098
74. Paulis L., Zicha J., Kunes J., Hojna S., Behuliak M., Celec P., Kojsova S., Pechanova O., Simko F., Regression of L-NAME-induced hypertension: the role of nitric oxide and endothelium-derived constricting factor. Hypertension Research 2008 31 4 793 803 2-s2.0-44649183901 10.1291/hypres.31.793 (Pubitemid 351772871)
75. Pecháňová O., Bernátová I., Pelouch V., Šimko F., Protein remodelling of the heart in NO-deficient hypertension: the effect of captopril. Journal of Molecular and Cellular Cardiology 1997 29 12 3365 3374 2-s2.0-0031459181 10.1006/jmcc.1997.0566 (Pubitemid 28039370)
76. Bernátová I., Pecháňová O., Šimko F., Effect of captopril in L-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney. Experimental Physiology 1999 84 6 1095 1105 2-s2.0-0344339118
77. Dillenburg D. R., Mostarda C., Moraes-Silva I. C., Ferreira D., Bos D. D., Duarte A. A., Irigoyen M. C., Rigatto K., Resveratrol and grape juice differentially ameliorate cardiovascular autonomic modulation in L-NAME-treated rats. Autonomic Neuroscience 2013 179 1-2 9 13
78. Nakmareong S., Kukongviriyapan U., Pakdeechote P., Kukongviriyapan V., Kongyingyoes B., Donpunha W., Prachaney P., Phisalaphong C., Tetrahydrocurcumin alleviates hypertension, aortic stiffening and oxidative stress in rats with nitric oxide deficiency. Hypertension Research 2012 35 4 418 425 2-s2.0-84859610682 10.1038/hr.2011.180
79. Babál P., Chronic inhibition of NO synthesis produces myocardial fibrosis and arterial media hyperplasia. Histology and Histopathology 1997 12 3 623 629 2-s2.0-0030848945 (Pubitemid 27314692)
80. Tsutsui M., Shimokawa H., Otsuji Y., Yanagihara N., Pathophysiological relevance of NO signaling in the cardiovascular system: novel insight from mice lacking all NO synthases. Pharmacology and Therapeutics 2010 128 3 499 508 2-s2.0-78049280211 10.1016/j.pharmthera.2010.08.010
81. Monshita T., Tsutsui M., Shimokawa H., Sabanai K., Tasaki H., Suda O., Nakata S., Tanimoto A., Wang K., Ueta Y., Sasaguri Y., Nakashima Y., Yanagihara N., Nephrogenic diabetes insipidus in mice lacking all nitric oxide synthase isoforms. Proceedings of the National Academy of Sciences of the United States of America 2005 102 30 10616 10621 2-s2.0-23044483861 10.1073/pnas.0502236102 (Pubitemid 41061603)
82. Huang P. L., Neuronal and endothelial nitric oxide synthase gene knockout mice. Brazilian Journal of Medical and Biological Research 1999 32 11 1353 1359 2-s2.0-0033219775 (Pubitemid 129544253)
83. Duplain H., Burcelin Ŕ., Sartori C., Cook S., Egli M., Lepori M., Vollenweider P., Pedrazzini T., Nicod P., Thorens B., Scherrer U., Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 2001 104 3 342 345 2-s2.0-0035902547 (Pubitemid 32666958)
84. le Gouill E., Jimenez M., Binnert C., Jayet P., Thalmann S., Nicod P., Scherrer U., Vollenweider P., Endothelial nitric oxide synthase (eNOS) knockout mice have defective mitochondrial β -oxidation. Diabetes 2007 56 11 2690 2696 2-s2.0-35748985277 10.2337/db06-1228 (Pubitemid 350044910)
85. Yamashita C., Tazawa N., Ohkita M., Matsumura Y., Exaggerated renal pathology of partial ablation-induced chronic renal failure in eNOS deficient mice. Biological and Pharmaceutical Bulletin 2008 31 5 1029 1031 2-s2.0-44349145452 10.1248/bpb.31.1029 (Pubitemid 351731991)
86. Lehnen A. M., Rodrigues B., Irigoyen M. C., de Angelis K., Schaan B. D., Cardiovascular changes in animal models of metabolic syndrome. Journal of Diabetes Research 2013 2013 11 761314 10.1155/2013/761314
87. Chou T., Yen M., Li C., Ding Y., Alterations of nitric oxide synthase expression with aging and hypertension in rats. Hypertension 1998 31 2 643 648 2-s2.0-0031886546 (Pubitemid 28086950)
88. Yang Q., Xue H., Wong W., Tian X., Huang Y., Tsui S. K., Ng P. K., Wohlfart P., Li H., Xia N., Tobias S., Underwood M. J., He G., AVE3085, an enhancer of endothelial nitric oxide synthase, restores endothelial function and reduces blood pressure in spontaneously hypertensive rats. British Journal of Pharmacology 2011 163 5 1078 1085 2-s2.0-79958789023 10.1111/j.1476-5381.2011. 01308.x
89. Kondrashov A., Vrankova S., Dovinova I., Sevcik R., Parohova J., Barta A., Pechanova O., Kovacsova M., The effects of new Alibernet red wine extract on nitric oxide and reactive oxygen species production in spontaneously hypertensive rats. Oxidative Medicine and Cellular Longevity 2012 2012 8 806285 10.1155/2012/806285
90. Nava E., Noll G., Luscher T. F., Increased activity of constitutive nitric oxide synthase in cardiac endothelium in spontaneous hypertension. Circulation 1995 91 9 2310 2313 2-s2.0-0028906693
91. Vaziri N. D., Ni Z., Oveisi F., Trnavsky-Hobbs D. L., Effect of antioxidant therapy on blood pressure and NO synthase expression in hypertensive rats. Hypertension 2000 36 6 957 964 2-s2.0-0033669975
92. Bernatova I., Csizmadiova Z., Kopincova J., Puzserova A., Vascular function and nitric oxide production in chronic social-stress-exposed rats with various family history of hypertension. Journal of Physiology and Pharmacology 2007 58 3 487 501 2-s2.0-34948828108 (Pubitemid 47523092)
93. Púzserová A., Csizmadiová Z., Berná tová I., Effect of blood pressure on L-NAME-sensitive component of vasorelaxation in adult rats. Physiological Research 2007 56 supplement 2 S77 S84 2-s2.0-34948902672
94. Caniffi C., Elesgaray R., Gironacci M., Arranz C., Costa M. Á., C-type natriuretic peptide effects on cardiovascular nitric oxide system in spontaneously hypertensive rats. Peptides 2010 31 7 1309 1318 2-s2.0-77952675862 10.1016/j.peptides.2010.03.030
95. Bernatova I., Conde M. V., Kopincova J., González M. C., Puzserova A., Arribas S. M., Endothelial dysfunction in spontaneously hypertensive rats: focus on methodological aspects. Journal of Hypertension 2009 27 S27 S31 2-s2.0-70349277005 10.1097/01.hjh.0000358834.18311.fc
96. Puzserova A., Kopincova J., Slezak P., Balis P., Bernatova I., Endothelial dysfunction in femoral artery of the hypertensive rats is nitric oxide independent. Physiological Research 2013 62 6 615 629
97. Mori Y., Ohyanagi M., Koida S., Ueda A., Ishiko K., Iwasaki T., Effects of endothelium-derived hyperpolariziing factor and nitric oxide on endothelial function in femoral resistance arteries of spontaneously hypertensive rats. Hypertension Research 2006 29 3 187 195 2-s2.0-33646065307 10.1291/hypres.29.187
98. Slezak P., Puzserova A., Balis P., Sestakova N., Majzunova M., Dovinova I., Kluknavsky M., Bernatova I., Genotype-related effect of crowding stress on blood pressure and vasular function in young female rats. BioMed Research International. In press
99. van de Voorde J., Vanheel B., Leusen I., Depressed endothelium-dependent relaxation in hypertension: relation to increased blood pressure and reversibility. Pflugers Archiv European Journal of Physiology 1988 411 5 500 504 2-s2.0-0023920048
100. Ungvari Z., Csiszar A., Kaminski P. M., Wolin M. S., Koller A., Chronic high pressure-induced arterial oxidative stress: involvement of protein kinase C-dependent NAD(P)H oxidase and local renin-angiotensin system. American Journal of Pathology 2004 165 1 219 226 2-s2.0-3042552707 (Pubitemid 38821829)
101. Condezo-Hoyos L., Arribas S. M., Abderrahim F., Somoza B., Gil-Ortega M., Díaz-Gil J. J., Victoria Conde M., Susin C., Carmen González M., Liver growth factor treatment reverses vascular and plasmatic oxidative stress in spontaneously hypertensive rats. Journal of Hypertension 2012 30 1185 1194 2-s2.0-84859894392 10.1097/HJH.0b013e328353824b
102. Huang C. F., Hsu C. N., Chien S. J., Lin Y. J., Huang L. T., Tain Y. L., Aminoguanidine attenuates hypertension, whereas 7-nitroindazole exacerbates kidney damage in spontaneously hypertensive rats: the role of nitric oxide. European Journal of Pharmacology 2013 699 233 240
103. 2+ oxidation by peroxynitrite implications for superoxide measurements in nitric oxide-producing biological systems. Archives of Biochemistry and Biophysics 1995 319 2 491 497 2-s2.0-0028977904 10.1006/abbi.1995.1321
104. Korbecki J., Baranowska-Bosiacka I., Gutowska I., Chlubek D., The effect of reactive oxygen species on the synthesis of prostanoids from arachidonic acid. Journal of Physiology and Pharmacology 2013 64 409 421
105. Matz R. L., de Sotomayor M. A., Schott C., Stoclet J.-C., Andriantsitohaina R., Vascular bed heterogeneity in age-related endothelial dysfunction with respect to NO and eicosanoids. British Journal of Pharmacology 2000 131 2 303 311 2-s2.0-0033778214
106. Forstermann U., Pollock J. S., Schmidt H. H. H. W., Heller M., Murad F., Calmodulin-dependent endothelium-derived relaxing factor/nitric oxide synthase activity is present in the particulate and cytosolic fractions of bovine aortic endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 1991 88 5 1788 1792 2-s2.0-0026071876 (Pubitemid 21916311)
107. Pandey D., Gratton J., Rafikov R., Black S. M., Fulton D. J. R., Calcium/calmodulin-dependent kinase II mediates the phosphorylation and activation of NADPH oxidase 5. Molecular Pharmacology 2011 80 3 407 415 2-s2.0-80051998706 10.1124/mol.110.070193
108. 2+ signals through endothelial TRPV4 channels regulate vascular function. Science 2012 336 6081 597 601 2-s2.0-84860476825 10.1126/science.1216283
109. 2+ sensitivity of arteriolar smooth muscle. Hypertension 2000 36 5 856 861 2-s2.0-0033695617
110. Wakui H., Dejima T., Tamura K., Uneda K., Azuma K., Maeda A., Ohsawa M., Kanaoka T., Azushima K., Kobayashi R., Matsuda M., Yamashita A., Umemura S., Activation of angiotensin II type 1 receptor-associated protein exerts an inhibitory effect on vascular hypertrophy and oxidative stress in angiotensin II-mediated hypertension. Cardiovascular Research 2013 100 511 519
111. Elmarakby A. A., Loomis E. D., Pollock J. S., Pollock D. M., NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1. Hypertension 2005 45 2 283 287 2-s2.0-13144293998 10.1161/01.HYP.0000153051.56460.6a (Pubitemid 40179973)
112. Zhou M., Schulman I. H., Pagano P. J., Jaimes E. A., Raij L., Reduced NAD(P)H oxidase in low renin hypertension: link among angiotensin II, atherogenesis, and blood pressure. Hypertension 2006 47 1 81 86 2-s2.0-31744449213 10.1161/01.HYP.0000197182.65554.c7 (Pubitemid 43177819)
113. Viel E. C., Benkirane K., Javeshghani D., Touyz R. M., Schiffrin E. L., Xanthine oxidase and mitochondria contribute to vascular superoxide anion generation in DOCA-salt hypertensive rats. American Journal of Physiology-Heart and Circulatory Physiology 2008 295 1 H281 H288 2-s2.0-49849095991 10.1152/ajpheart.00304.2008
114. Gómez-Guzmán M., Jiménez R., Sánchez M., Zarzuelo M. J., Galindo P., Quintela A. M., López-Sepúlveda R., Romero M., Tamargo J., Vargas F., Pérez-Vizcaíno F., Duarte J., Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension. Free Radical Biology and Medicine 2012 52 1 70 79 2-s2.0-84655165055 10.1016/j.freeradbiomed.2011.09.015
115. Al-Awwadi N. A., Araiz C., Bornet A., Delbosc S., Cristol J., Linck N., Azay J., Teissedre P., Cros G., Extracts enriched in different polyphenolic families normalize increased cardiac NADPH oxidase expression while having differential effects on insulin resistance, hypertension, and cardiac hypertrophy in high-fructose-fed rats. Journal of Agricultural and Food Chemistry 2005 53 1 151 157 2-s2.0-11244292338 10.1021/jf048919f (Pubitemid 40066483)
116. Korandji C., Zeller M., Guilland J. C., Collin B., Lauzier B., Sicard P., Duvillard L., Goirand F., Moreau D., Cottin Y., Rochette L., Vergely C., Time course of asymmetric dimethylarginine (ADMA) and oxidative stress in fructose-hypertensive rats: a model related to metabolic syndrome. Atherosclerosis 2011 214 2 310 315 2-s2.0-79151483944 10.1016/j.atherosclerosis. 2010.11.014
117. Vaziri N. D., Sica D. A., Lead-induced hypertension: role of oxidative stress. Current Hypertension Reports 2004 6 4 314 320 2-s2.0-4344597081 (Pubitemid 39144657)
118. Zhou M., Nishida Y., Chen Q., Kosaka H., Endothelium-derived contracting factor in carotid artery of hypertensive Dahl rats. Hypertension 1999 34 1 39 43 2-s2.0-0032793665 (Pubitemid 29325716)
119. Lukaszewicz K. M., Lombard J. H., Role of the CYP4A/20-HETE pathway in vascular dysfunction of the Dahl salt-sensitive rat. Clinical Science 2013 124 695 700
120. Barton M., D'Uscio L. V., Shaw S., Meyer P., Moreau P., Lüscher T. F., ET(A) receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension. Hypertension 1998 31 1 499 504 2-s2.0-0031613530
121. Zicha J., Dobešová Z., Kuneš J., Vaněčková I., Chronic endothelin A receptor blockade attenuates contribution of sympathetic nervous system to salt hypertension development in adult but not in young Dahl rats. Acta Physiologica 2012 205 1 124 132 2-s2.0-84859146045 10.1111/j.1748-1716.2012.02395.x
122. Cao Y., Mu J. J., Fang Y., Yuan Z. Y., Liu F. Q., Impact of high salt
123. Tian N., Gannon A. W., Khalil R. A., Manning R. D. Jr., Mechanisms of salt-sensitive hypertension: role of renal medullary inducible nitric oxide synthase. American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2003 284 2 R372 R379 2-s2.0-0037304203 (Pubitemid 36120153)
124. Lariviere R., Deng L. Y., Day R., Sventek P., Thibault G., Schiffrin E. L., Increased endothelin-1 gene expression in the endothelium of coronary arteries and endocardium in the DOCA-salt hypertensive rat. Journal of Molecular and Cellular Cardiology 1995 27 10 2123 2131 2-s2.0-0028862412
125. Adeagbo A. S. O., Zhang X., Patel D., Joshua I. G., Wang Y., Sun X., Igbo I. N., Oriowo M. A., Cyclo-oxygenase-2, endothelium and aortic reactivity during deoxycorticosterone acetate salt-induced hypertension. Journal of Hypertension 2005 23 5 1025 1036 2-s2.0-18344379715 (Pubitemid 40637922)
126. Adeagbo A. S. O., Joshua I. G., Falkner C., Matheson P. J., Tempol, an antioxidant, restores endothelium-derived hyperpolarizing factor-mediated vasodilation during hypertension. European Journal of Pharmacology 2003 481 1 91 100 2-s2.0-0344585447 10.1016/j.ejphar.2003.09.005 (Pubitemid 37456792)
127. Dumont A. S., Hyndman M. E., Dumont R. J., Fedak P. M., Kassell N. F., Sutherland G. R., Verma S., Improvement of endothelial function in insulin-resistant carotid arteries treated with pravastatin. Journal of Neurosurgery 2001 95 3 466 471 2-s2.0-0034865882 (Pubitemid 32781499)
128. Lee D. H., Lee J., Kang D. G., Paek Y. W., Chung D. J., Chung M. Y., Increased vascular endothelin-1 gene expression with unaltered nitric oxide synthase levels in fructose-induced hypertensive rats. Metabolism 2001 50 1 74 78 2-s2.0-0035180217 10.1053/meta.2001.19527 (Pubitemid 32058552)
129. Navarro-Cid J., Maeso R., Perez-Vizcaino F., Cachofeiro V., Ruilope L. M., Tamargo J., Lahera V., Effects of losartan on blood pressure, metabolic alterations, and vascular reactivity in the fructose-induced hypertensive rat. Hypertension 1995 26 6 1074 1078 2-s2.0-0028883839
130. Esler M., Eikelis N., Schlaich M., Lambert G., Alvarenga M., Dawood T., Kaye D., Barton D., Pier C., Guo L., Brenchley C., Jennings G., Lambert E., Chronic mental stress is a cause of essential hypertension: presence of biological markers of stress. Clinical and Experimental Pharmacology and Physiology 2008 35 4 498 502 2-s2.0-40149100191 10.1111/j.1440-1681.2008.04904.x (Pubitemid 351326787)
131. Sparrenberger F., Fuchs S. C., Moreira L. B., Fuchs F. D., Stressful life events and current psychological distress are associated with self-reported hypertension but not with true hypertension: results from a cross-sectional population-based study. BMC Public Health 2008 8, article 357 2-s2.0-57549116388 10.1186/1471-2458-8-357
132. Fokkema D. S., Koolhaas J. M., van der Meulen J., Schoemaker R., Social stress induced pressure breathing and consequent blood pressure oscillation. Life Sciences 1986 38 6 569 575 2-s2.0-0022621211 (Pubitemid 16164031)
133. Andrews E., Jenkins C., Seachrist D., Dunphy G., Ely D., Social stress increases blood pressure and cardiovascular pathology in a normotensive rat model. Clinical and Experimental Hypertension 2003 25 2 85 101 2-s2.0-0037328746 10.1081/CEH-120017930 (Pubitemid 36232297)
134. Harrap S. B., Louis W. J., Doyle A. E., Failure of psychosocial stress to induce chronic hypertension in the rat. Journal of Hypertension 1984 2 6 653 662 2-s2.0-0021713312 (Pubitemid 15188017)
135. Lemaire V., Mormède P., Telemetered recording of blood pressure and heart rate in different strains of rats during chronic social stress. Physiology and Behavior 1995 58 6 1181 1188 2-s2.0-0029585488 10.1016/0031-9384(95)02064-0 (Pubitemid 26003581)
136. Mansi J. A., Drolet G., Chronic stress induces sensitization in sympathoadrenal responses to stress in borderline hypertensive rats. American Journal of Physiology-Regulatory Integrative and Comparative Physiology 1997 272 3 R813 R820 2-s2.0-0030910654
137. Sanders B. J., Lawler J. E., The borderline hypertensive rat (BHR) as a model for environmentally- induced hypertension: a review and update. Neuroscience and Biobehavioral Reviews 1992 16 2 207 217 2-s2.0-0026748472 10.1016/S0149-7634(05)80181-2
138. Bernatova I., Csizmadiova Z., Effect of chronic social stress on nitric oxide synthesis and vascular function in rats with family history of hypertension. Life Sciences 2006 78 15 1726 1732 2-s2.0-33244487002 10.1016/j.lfs.2005.08.005 (Pubitemid 43276480)
139. Fleming I., Baum A., Davidson L. M., Rectanus E., McArdle S., Chronic stress as a factor in physiologic reactivity to challenge. Health Psychology 1987 6 3 221 237 2-s2.0-0023082452
140. D'Atri D. A., Fitzgerald E. F., Kasl S. V., Ostfeld A. M., Crowding in prison: the relationship between changes in housing mode and blood pressure. Psychosomatic Medicine 1981 43 2 95 105 2-s2.0-0019519228 (Pubitemid 11117379)
141. Púzserová A., Csizmadiová Z., Andriantsitohaina R., Bernátová I., Vascular effects of red wine polyphenols in chronic stress-exposed Wistar-Kyoto rats. Physiological Research 2006 55 supplement 1 S39 S47 2-s2.0-33847092535
142. Bernatova I., Puzserova A., Dubovicky M., Sex differences in social stress-induced pressor and behavioral responses in normotensive and prehypertensive rats. General Physiology and Biophysics 2010 29 4 346 354 2-s2.0-78650639884 10.4149/gpb-2010-04-346
143. Puzserova A., Slezak P., Balis P., Bernatova I., Long-term social stress induces nitric oxide-independent endothelial dysfunction in normotensive rats. Stress 2013 16 331 339
144. Bernátová I., Púzserová A., Navarová J., Csizmadiová Z., Zeman M., Crowding-induced alterations in vascular system of Wistar-Kyoto rats: role of nitric oxide. Physiological Research 2007 56 5 667 669 2-s2.0-36849070462
145. Fuchs L. C., Hoque A. M., Clarke N. L., Vascular and hemodynamic effects of behavioral stress in borderline hypertensive and Wistar-Kyoto rats. American Journal of Physiology-Regulatory Integrative and Comparative Physiology 1998 274 2 R375 R382 2-s2.0-0031992146
146. Fuchs L. C., Landas S. K., Johnson A. K., Behavioral stress alters coronary vascular reactivity in borderline hypertensive rats. Journal of Hypertension 1997 15 3 301 307 2-s2.0-0030992449 10.1097/00004872-199715030- 00012 (Pubitemid 27129120)
147. Giulumian A. D., Clark S. G., Fuchs L. C., Effect of behavioral stress on coronary artery relaxation altered with aging in BHR. American Journal of Physiology-Regulatory Integrative and Comparative Physiology 1999 276 2 R435 R440 2-s2.0-0033046068 (Pubitemid 29098678)
148. Balkaya M., Prinz V., Custodis F., Gertz K., Kronenberg G., Kroeber J., Fink K., Plehm R., Gass P., Laufs U., Endres M., Stress worsens endothelial function and ischemic stroke via glucocorticoids. Stroke 2011 42 11 3258 3264 2-s2.0-80055021527 10.1161/STROKEAHA.110.607705
149. Radomski M. W., Palmer R. M. J., Moncada S., Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 1990 87 24 10043 10047 2-s2.0-0025672648 10.1073/pnas.87.24.10043 (Pubitemid 120016581)
150. Rogers K. M., Bonar C. A., Estrella J. L., Yang S., Inhibitory effect of glucocorticoid on coronary artery endothelial function. American Journal of Physiology-Heart and Circulatory Physiology 2002 283 5 H1922 H1928 2-s2.0-0036839107 (Pubitemid 35217026)
151. Wallerath T., Witte K., Schäfer S. C., Schwarz P. M., Prellwitz W., Wohlfart P., Kleinert H., Lehr H., Lemmer B., Förstermann U., Down-regulation of the expression of endothelial NO synthase is likely to contribute to qlucocorticoid-mediated hypertension. Proceedings of the National Academy of Sciences of the United States of America 1999 96 23 13357 13362 2-s2.0-0033539502
152. Simmons W. W., Ungureanu-Longrois D., Smith G. K., Smith T. W., Kelly R. A., Glucocorticoids regulate inducible nitric oxide synthase by inhibiting tetrahydrobiopterin synthesis and L-arginine transport. The Journal of Biological Chemistry 1996 271 39 23928 23937 2-s2.0-0029793534 10.1074/jbc.271.39.23928 (Pubitemid 26327368)
153. Liu Y., Mladinov D., Pietrusz J. L., Usa K., Liang M., Glucocorticoid response elements and 11 β -hydroxysteroid dehydrogenases in the regulation of endothelial nitric oxide synthase expression. Cardiovascular Research 2009 81 1 140 147 2-s2.0-57749171127 10.1093/cvr/cvn231
154. Jun S. S., Chen Z., Pace M. C., Shaul P. W., Glucocorticoids downregulate cyclooxygenase-1 gene expression and prostacyclin synthesis in fetal pulmonary artery endothelium. Circulation Research 1999 84 2 193 200 2-s2.0-0033524664 (Pubitemid 29070115)
155. Zafir A., Banu N., Induction of oxidative stress by restraint stress and corticosterone treatments in rats. Indian Journal of Biochemistry and Biophysics 2009 46 1 53 58 2-s2.0-65549095855
156. Malyshev I. Y., Manukhina E. B., Stress, adaptation, and nitric oxide. Biochemistry 1998 63 7 840 853 2-s2.0-0032112770 (Pubitemid 128588114)
157. Stefano G. B., Fricchione G. L., Esch T., Relaxation: molecular and physiological significance. Medical Science Monitor 2006 12 9 HY21 HY31 2-s2.0-33748535117 (Pubitemid 44371892)